Back to search
Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma trials you may qualify forSpecific immunotherapy for IgE mediated sensitization to birch pollen. Long-term study to assess safety and efficacy of Depigoid(R)Birch 5000 - a modified polle…
Safety study of Depigoid vaccine Dermatophagoides pteronyssinus or 50% Dermatophagoides pteronyssinus / 50% Dermatophagoides farinae (500 DPP/ml), to treat alle…
This study will assess efficacy and safety of intraseasonal specific short-term immunotherapy with Depiquick® Birch in patients with allergic rhinitis and or rh…
Specific immunotherapy for IgE mediated sensitization to grass pollen 4 concentrations of a modified pollen extract of Phleum pratense are applied to find out…
Specific immunotherapy for subcutaneous application: Dose finding study to evaluate the correct dose. 4 concentrations of a birch pollen allergen extract are a…